bupivacaine/dextrose / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bupivacaine/dextrose / Generic mfg.
SAFER-L, NCT03715517: Spinal Anesthesia For Enhanced Recovery After Liver Surgery

Recruiting
N/A
128
Canada
Continuous thoracic epidural analgesia, Spinal anesthesia with intrathecal morphine, Bupivacaine 0.75% in Dextrose Inj 8.25%, Spinal heavy bupivacaine, Morphine, Intrathecal morphine, Bupivacaine 0.25% Preservative-Free Injectable Solution, Bupivacaine 0.25% epidural solution, Bupicavaine 0.125% epidural solution, Bupivacaine 0.125% preservative-free injectable solution, Hydromorphone 10 mcg/mL epidural solution
University of Manitoba
Hepatectomy, Pain, Postoperative, Liver Neoplasms
12/25
01/26
NCT05374356: High Spinal Anesthesia and the Incidence of Delirium After Cardiac Surgery

Active, not recruiting
N/A
50
Canada
Intrathecal bupivacaine and morphine, Drug: bupivacaine 0.75% in dextrose (0.3 to 0.6 mls/kg), Drug: preservative free morphine 3 mcg/kg
University of Manitoba
Post-Operative Confusion
06/24
06/24
NCT06206044: Evaluation of the Typical Spinal Block During Cesarean Delivery

Enrolling by invitation
N/A
250
US
Intrathecal 1.6 ml 0.75% bupivacaine in 8.25% dextrose combined with 15 mcg fentanyl and 150 mcg preservative-free morphine, Marcaine
Oregon Health and Science University
Cesarean Section, Anesthesia, Obstetric
12/25
01/26

Download Options